1 – 10 of 76
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
PRR11 unveiled as a top candidate biomarker within the RBM3-regulated transcriptome in pancreatic cancer
(
- Contribution to journal › Article
-
Mark
Low-grade inflammation in survivors of childhood cancer and testicular cancer and its association with hypogonadism and metabolic risk factors
(
- Contribution to journal › Article
-
Mark
Delineating the intra-patient heterogeneity of molecular alterations in treatment-naïve colorectal cancer with peritoneal carcinomatosis
2022) In Modern Pathology(
- Contribution to journal › Article
- 2021
-
Mark
Clinical significance of RBM3 expression in surgically treated colorectal lung metastases and paired primary tumours
(
- Contribution to journal › Article
-
Mark
Randomized Phase II trial of combination chemotherapy with panitumumab or bevacizumab for patients with inoperable biliary tract cancer without KRAS exon 2 mutations
(
- Contribution to journal › Article
-
Mark
Second-line palliative chemotherapy, survival, and prognostic factors in patients with advanced pancreatic cancer
(
- Contribution to journal › Article
- 2020
-
Mark
Palliative short-course hypofractionated radiotherapy followed by chemotherapy in esophageal adenocarcinoma : the phase II PALAESTRA trial
(
- Contribution to journal › Article
-
Mark
Chemotherapy, host response and molecular dynamics in periampullary cancer : The CHAMP study
(
- Contribution to journal › Article
-
Mark
Additive clinical impact of epidermal growth factor receptor and podocalyxin-like protein expression in pancreatic and periampullary adenocarcinomas
(
- Contribution to journal › Article
- 2019
-
Mark
Sperm count in Swedish clinical stage I testicular cancer patients following adjuvant treatment
2019) In Annals of oncology : official journal of the European Society for Medical Oncology 30(4). p.604-611(
- Contribution to journal › Article